Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes), Application (Cancer, Diabetes), Facility of Use (Hospitals), COVID-19 Impact - Global Forecast to 2030
Market Overview
Fatpos Global has released a report titled Pharmaceutical Drug Delivery Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According to a study by Fatpos Global, is anticipated to reachUSD 2,206.5 billion by 2030 from USD 1,656.9 billion in 2021, at a CAGR of 5.9% during the forecast period
According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Pharmaceutical Drug Delivery Market Market: Key Players
Johnson & Johnson (US),
Novartis International AG (Switzerland),
F. Hoffmann-La Roche AG (Switzerland),
Pfizer Inc. (US), Bayer AG (Germany)
Antares Pharma, Inc. (US),
Becton, Dickinson and Company (US),
GlaxoSmithKline plc (UK), 3M (US),
Merck & Co., Inc. (US), Sanofi (France),
Amgen, Inc. (US), AbbVie Inc. (US),
Genmab A/S (Denmark), Gilead Sciences, Inc. (US),
Boehringer Ingelheim (Germany),
AstraZeneca plc. (UK),
Eli Lilly and Company (US),
Teva Pharmaceuticals Industries Ltd. (Israel),
Bristol-Myers Squibb (US),
Gerresheimer AG (Germany),
Boston Scientific Corporation (US),
Nimbus Therapeutics (US),
Kite Pharma (US), and
IDEAYA Biosciences, Inc. (US).
Segmentation
Global pharmaceutical drug delivery market, by Route of Administration
Oral Drug Delivery
Injectable Drug Delivery
Topical Drug Delivery
Ocular Drug Delivery
Pulmonary Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Nasal Drug Delivery
Global pharmaceutical drug delivery market, by Application
Infectious Diseases
Cancer
Cardiovascular Diseases
Diabetes
Respiratory Diseases
Central Nervous System Disorders
Autoimmune Diseases
Other Applications
Global pharmaceutical drug delivery market, by Facility of Use
Hospitals
Ambulatory Surgery Ceters
Home Care Settings
Diagnostic Centers
Other Facilities of Use
Global pharmaceutical drug delivery market, by Region
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia
China
Japan
India
Rest of Asia
Latin America
Middle East & Africa
Pharmaceutical Drug Delivery Market Market Dynamics
Pharmaceutical Drug Delivery Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Pharmaceutical Drug Delivery Market Market growth?
Which segment accounted for the largest Pharmaceutical Drug Delivery Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*
- 1. Executive Summary
- 2. Pharmaceutical Drug Delivery Market
- 2.1. Product Overview
- 2.2. Market Definition
- 2.3. Segmentation
- 2.4. Assumptions and Acronyms
- 3. Research Methodology
- 3.1. Research Objectives
- 3.2. Primary Research
- 3.3. Secondary Research
- 3.4. Forecast Model
- 3.5. Market Size Estimation
- 4. Average Pricing Analysis
- 5. Macro-Economic Indicators
- 6. Market Dynamics
- 6.1. Growth Drivers
- 6.2. Restraints
- 6.3. Opportunity
- 6.4. Trends
- 7. Correlation & Regression Analysis
- 7.1. Correlation Matrix
- 7.2. Regression Matrix
- 8. Recent Development, Policies & Regulatory Landscape
- 9. Risk Analysis
- 9.1. Demand Risk Analysis
- 9.2. Supply Risk Analysis
- 10. Pharmaceutical Drug Delivery Market Analysis
- 10.1. Porters Five Forces
- 10.1.1. Threat of New Entrants
- 10.1.2. Bargaining Power of Suppliers
- 10.1.3. Threat of Substitutes
- 10.1.4. Rivalry
- 10.2. PEST Analysis
- 10.2.1. Political
- 10.2.2. Economic
- 10.2.3. Social
- 10.2.4. Technological
- 11. Pharmaceutical Drug Delivery Market
- 11.1. Market Size & forecast, 2020A-2030F
- 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12. Pharmaceutical Drug Delivery Market: Market Segmentation
- 12.1. By Regions
- 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2. By network type: Market Share (2020-2030F)
- 12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3. By End user: Market Share (2020-2030F)
- 12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- 12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
- Company Profile
- Johnson & Johnson (US),
- Novartis International AG (Switzerland),
- F. Hoffmann-La Roche AG (Switzerland),
- Pfizer Inc. (US), Bayer AG (Germany)
- Antares Pharma, Inc. (US),
- Becton, Dickinson and Company (US),
- GlaxoSmithKline plc (UK), 3M (US),
- Merck & Co., Inc. (US), Sanofi (France),
- Amgen, Inc. (US), AbbVie Inc. (US),
- Genmab A/S (Denmark), Gilead Sciences, Inc. (US),
- Boehringer Ingelheim (Germany),
- AstraZeneca plc. (UK),
- Eli Lilly and Company (US),
- Teva Pharmaceuticals Industries Ltd. (Israel),
- Bristol-Myers Squibb (US),
- Gerresheimer AG (Germany),
- Boston Scientific Corporation (US),
- Nimbus Therapeutics (US),
- Kite Pharma (US), and
- IDEAYA Biosciences, Inc. (US).
- Consultant Recommendation
- **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook